Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

The toxic effect of cytostatics on primary cilia frequency and multiciliation.

Filipová A, Diaz Garcia D, Bezrouk A, Čížková D, Dvořák J, Filip S, Sturge J, Šinkorová Z.

J Cell Mol Med. 2019 Aug;23(8):5728-5736. doi: 10.1111/jcmm.14487. Epub 2019 Jun 17.

2.

A 18F radiolabelled Zn(ii) sensing fluorescent probe.

Price TW, Firth G, Eling CJ, Kinnon M, Long NJ, Sturge J, Stasiuk GJ.

Chem Commun (Camb). 2018 Mar 27;54(26):3227-3230. doi: 10.1039/c8cc00687c.

PMID:
29528355
3.

How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases.

Rodriguez-Teja M, Breit C, Clarke M, Talar K, Wang K, Mohammad MA, Pickwell S, Etchandy G, Stasiuk GJ, Sturge J.

J Vis Exp. 2016 Sep 20;(115). doi: 10.3791/54230.

4.

Endo180 at the cutting edge of bone cancer treatment and beyond.

Sturge J.

J Pathol. 2016 Mar;238(4):485-8. doi: 10.1002/path.4673. Epub 2016 Jan 11. Review.

5.

Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces.

Caley MP, King H, Shah N, Wang K, Rodriguez-Teja M, Gronau JH, Waxman J, Sturge J.

Clin Exp Metastasis. 2016 Feb;33(2):151-65. doi: 10.1007/s10585-015-9765-7. Epub 2015 Nov 13.

6.

LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression.

Mura M, Hopkins TG, Michael T, Abd-Latip N, Weir J, Aboagye E, Mauri F, Jameson C, Sturge J, Gabra H, Bushell M, Willis AE, Curry E, Blagden SP.

Oncogene. 2015 Sep 24;34(39):5025-36. doi: 10.1038/onc.2014.428. Epub 2014 Dec 22.

7.

AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival.

Rodriguez-Teja M, Gronau JH, Breit C, Zhang YZ, Minamidate A, Caley MP, McCarthy A, Cox TR, Erler JT, Gaughan L, Darby S, Robson C, Mauri F, Waxman J, Sturge J.

J Pathol. 2015 Mar;235(4):581-92. doi: 10.1002/path.4485. Epub 2014 Dec 24.

PMID:
25408555
8.

Survival Outcome and EMT Suppression Mediated by a Lectin Domain Interaction of Endo180 and CD147.

Rodriguez-Teja M, Gronau JH, Minamidate A, Darby S, Gaughan L, Robson C, Mauri F, Waxman J, Sturge J.

Mol Cancer Res. 2015 Mar;13(3):538-47. doi: 10.1158/1541-7786.MCR-14-0344-T. Epub 2014 Nov 7.

9.

Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer.

Palmieri C, Caley MP, Purshouse K, Fonseca AV, Rodriguez-Teja M, Kogianni G, Woodley L, Odendaal J, Elliott K, Waxman J, Sturge J.

Br J Cancer. 2013 Jan 15;108(1):163-9. doi: 10.1038/bjc.2012.540. Epub 2012 Dec 20.

10.

Fluorescence-based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cells.

Ramasamy K, Khatun H, Macpherson L, Caley MP, Sturge J, Mufti GJ, Schey SA, Calle Y.

Br J Haematol. 2012 Jun;157(5):564-79. doi: 10.1111/j.1365-2141.2012.09103.x. Epub 2012 Mar 20.

PMID:
22428569
11.

Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection.

Nunes J, Naymark M, Sauer L, Muhammad A, Keun H, Sturge J, Stebbing J, Waxman J, Pchejetski D.

Br J Cancer. 2012 Feb 28;106(5):909-15. doi: 10.1038/bjc.2012.14. Epub 2012 Feb 7.

12.

TGFβ1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasis.

Caley MP, Kogianni G, Adamarek A, Gronau JH, Rodriguez-Teja M, Fonseca AV, Mauri F, Sandison A, Rhim JS, Pchejetski D, Palmieri C, Cobb JP, Waxman J, Sturge J.

J Pathol. 2012 Apr;226(5):775-83. doi: 10.1002/path.3958. Epub 2011 Dec 8. Erratum in: J Pathol. 2013 Feb;229(3):e4. Pchejetski, Dmitri [added].

PMID:
22072289
13.

Bone metastasis in prostate cancer: emerging therapeutic strategies.

Sturge J, Caley MP, Waxman J.

Nat Rev Clin Oncol. 2011 Jun;8(6):357-68. doi: 10.1038/nrclinonc.2011.67. Epub 2011 May 10. Review. Erratum in: Nat Rev Clin Oncol. 2011 Oct;8(10):568.

PMID:
21556025
14.

Biological and clinical implications of nicastrin expression in invasive breast cancer.

Filipović A, Gronau JH, Green AR, Wang J, Vallath S, Shao D, Rasul S, Ellis IO, Yagüe E, Sturge J, Coombes RC.

Breast Cancer Res Treat. 2011 Jan;125(1):43-53. doi: 10.1007/s10549-010-0823-1. Epub 2010 Mar 12.

PMID:
20224929
15.

Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression.

Kogianni G, Walker MM, Waxman J, Sturge J.

Eur J Cancer. 2009 Mar;45(4):685-93. doi: 10.1016/j.ejca.2008.11.023. Epub 2008 Dec 26.

PMID:
19112015
16.

The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivo.

Wienke D, Davies GC, Johnson DA, Sturge J, Lambros MB, Savage K, Elsheikh SE, Green AR, Ellis IO, Robertson D, Reis-Filho JS, Isacke CM.

Cancer Res. 2007 Nov 1;67(21):10230-40.

17.

Mannose receptor regulation of macrophage cell migration.

Sturge J, Todd SK, Kogianni G, McCarthy A, Isacke CM.

J Leukoc Biol. 2007 Sep;82(3):585-93. Epub 2007 Jun 27.

PMID:
17596337
18.

Interventions to reduce harm associated with adolescent substance use.

Toumbourou JW, Stockwell T, Neighbors C, Marlatt GA, Sturge J, Rehm J.

Lancet. 2007 Apr 21;369(9570):1391-1401. doi: 10.1016/S0140-6736(07)60369-9. Review.

PMID:
17448826
19.

Endosomes generate localized Rho-ROCK-MLC2-based contractile signals via Endo180 to promote adhesion disassembly.

Sturge J, Wienke D, Isacke CM.

J Cell Biol. 2006 Oct 23;175(2):337-47. Epub 2006 Oct 16.

20.

GPI-anchored uPAR requires Endo180 for rapid directional sensing during chemotaxis.

Sturge J, Wienke D, East L, Jones GE, Isacke CM.

J Cell Biol. 2003 Sep 1;162(5):789-94.

21.

A targeted deletion in the endocytic receptor gene Endo180 results in a defect in collagen uptake.

East L, McCarthy A, Wienke D, Sturge J, Ashworth A, Isacke CM.

EMBO Rep. 2003 Jul;4(7):710-6.

22.

Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta.

Sawyer C, Sturge J, Bennett DC, O'Hare MJ, Allen WE, Bain J, Jones GE, Vanhaesebroeck B.

Cancer Res. 2003 Apr 1;63(7):1667-75.

24.
25.

Regulation by fibrinogen and its products of intercellular adhesion molecule-1 expression in human saphenous vein endothelial cells.

Harley SL, Sturge J, Powell JT.

Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):652-8.

PMID:
10712387
26.

Urine antibody tests: new insights into the dynamics of HIV-1 infection.

Urnovitz HB, Sturge JC, Gottfried TD, Murphy WH.

Clin Chem. 1999 Sep;45(9):1602-13.

27.

A urine test system for HIV-1 antibodies.

Gottfried TD, Sturge JC, Urnovitz HB.

Am Clin Lab. 1999 Jan-Feb;18(1):4. No abstract available.

PMID:
10351123
28.

Increased sensitivity of HIV-1 antibody detection.

Urnovitz HB, Sturge JC, Gottfried TD.

Nat Med. 1997 Nov;3(11):1258.

PMID:
9359701
29.

Evaluation of blood collected on filter paper for detection of antibodies to human immunodeficiency virus type 1.

Fortes P, Menitove J, Ross A, Steece R, Cabrian K, Ferrera C, Perkins PA, Sturge J, Lealos R, Krieger MS.

J Clin Microbiol. 1989 Jun;27(6):1380-1.

30.

Checking on those who care for children.

Sturge JC.

BMJ. 1989 Apr 1;298(6677):844-5. No abstract available.

31.

Joint work in paediatrics: a child psychiatry perspective.

Sturge JC.

Arch Dis Child. 1989 Jan;64(1):155-8. No abstract available.

32.

Legionella micdadei and Legionella dumoffii monoclonal antibodies for laboratory diagnosis of Legionella infections.

Cercenado E, Edelstein PH, Gosting LH, Sturge JC.

J Clin Microbiol. 1987 Nov;25(11):2163-7.

33.
34.

Clinical utility of a monoclonal direct fluorescent reagent specific for Legionella pneumophila: comparative study with other reagents.

Edelstein PH, Beer KB, Sturge JC, Watson AJ, Goldstein LC.

J Clin Microbiol. 1985 Sep;22(3):419-21.

35.

Confirmation of Legionella pneumophila cultures with a fluorescein-labeled monoclonal antibody.

Tenover FC, Carlson L, Goldstein L, Sturge J, Plorde JJ.

J Clin Microbiol. 1985 Jun;21(6):983-4.

36.

Identification of a species-specific antigen in Legionella pneumophila by a monoclonal antibody.

Gosting LH, Cabrian K, Sturge JC, Goldstein LC.

J Clin Microbiol. 1984 Dec;20(6):1031-5.

37.

Induction of target antigens and conversion to susceptible phenotype of NK-cell-resistant lymphoid cell line.

Clark EA, Sturge JC, Falk LA Jr.

Int J Cancer. 1981 Nov 15;28(5):647-54.

PMID:
7309297
40.

Monocyte-reactive antibodies in patients with systemic lupus erythematosus.

Arend WP, Emmerich TE, Sturge JC, Starkebaum GA.

Arthritis Rheum. 1977 Jun;20(5):1049-57.

PMID:
68777

Supplemental Content

Loading ...
Support Center